Ignite Creation Date:
2025-12-24 @ 2:29 PM
Ignite Modification Date:
2026-01-19 @ 9:14 AM
Study NCT ID:
NCT00796159
Status:
COMPLETED
Last Update Posted:
2009-12-23
First Post:
2008-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A0021004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Director, Clinical Trial Disclosure Group
Old Organization:
Pfizer, Inc.